|
Re: ITC Filing Respondents’ motions for leave should be granted....Opty and all
|
3
|
Mosaic ImmunoEngineering Inc.
|
Apr 18, 2013 12:18AM
|
|
Re: It is important
|
3
|
Mosaic ImmunoEngineering Inc.
|
Apr 14, 2012 12:18PM
|
|
Re: Responseon Shareholders meeting...mikes
|
3
|
Mosaic ImmunoEngineering Inc.
|
Jan 22, 2013 07:16PM
|
|
Re: another Markman PR......opty and all
|
3
|
Mosaic ImmunoEngineering Inc.
|
Jan 11, 2013 02:17PM
|
|
Re: FESS UP .. Who contracted for that OTCMagic Promotional tout sheet ?
|
3
|
Mosaic ImmunoEngineering Inc.
|
Aug 30, 2012 12:40AM
|
|
One possible way the ITC could be overrulled, although timeframe
|
3
|
Mosaic ImmunoEngineering Inc.
|
Oct 06, 2013 01:00AM
|
|
Re: next q report
|
3
|
Mosaic ImmunoEngineering Inc.
|
Nov 12, 2012 04:17PM
|
|
Re: The silence is somehow strange.....
|
3
|
Mosaic ImmunoEngineering Inc.
|
Apr 10, 2012 02:12PM
|
|
More likely than not
|
3
|
Mosaic ImmunoEngineering Inc.
|
Nov 30, 2012 01:53PM
|
|
Re: To pass the time ...
|
3
|
Mosaic ImmunoEngineering Inc.
|
May 18, 2012 02:56PM
|
|
Re: Claims Briefs and Summary Judgement Denial
|
3
|
Mosaic ImmunoEngineering Inc.
|
Apr 12, 2012 10:04AM
|
|
Question for SHM
|
3
|
Mosaic ImmunoEngineering Inc.
|
Apr 24, 2013 10:53AM
|
|
Apologies to the board ...
|
3
|
Mosaic ImmunoEngineering Inc.
|
Jul 25, 2012 11:01PM
|
|
Re: During the three months ended August 31, 2012 and 2011...
|
3
|
Mosaic ImmunoEngineering Inc.
|
Oct 15, 2012 10:03PM
|
|
Re: wow, 80% short interest as of jan 17th
|
3
|
Mosaic ImmunoEngineering Inc.
|
Jan 18, 2013 11:06AM
|
|
Re: To be CLEAR - $42M estimate is to PDS - NOT PTSC
|
3
|
Mosaic ImmunoEngineering Inc.
|
Mar 16, 2012 07:37PM
|
|
T3 Strategy & Thanks to Wolf
|
3
|
Mosaic ImmunoEngineering Inc.
|
Jan 16, 2012 03:15PM
|
|
Palomar
|
3
|
Mosaic ImmunoEngineering Inc.
|
Oct 28, 2013 11:51AM
|
|
Hopefully this is our argument ...
|
3
|
Mosaic ImmunoEngineering Inc.
|
Jun 12, 2013 11:11PM
|
|
Re: Hopefully this is our argument ... More
|
3
|
Mosaic ImmunoEngineering Inc.
|
Jun 12, 2013 11:24PM
|
